malaria vaccine

Investigational PfSPZ Malaria Vaccine Proves Its Efficacy For Plasmodium Falciparum Malaria

An investigational malaria vaccine given intravenously was well-tolerated and protected a significant proportion of healthy adults against infection with Plasmodium falciparum malaria — the deadliest form of the disease — for the duration of the malaria season, according to new findings published in the February 15th issue of the journal Lancet Infectious Diseases. The study participants live in Mali, Africa, where they are naturally exposed to the parasite.



FDA Expands Approval SPIRIVA RESPIMAT

FDA Expands Approval of SPIRIVA® RESPIMAT®

  • FDA Expands Approval of SPIRIVA® RESPIMAT®, Steroid-free Respimat now approved as asthma treatment for age 6 and older
  • Supplemental New Drug Application (sNDA) approved under priority review from the FDA
  • FDA also granted pediatric exclusivity to SPIRIVA

Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved SPIRIVA RESPIMAT for the long-term, once-daily maintenance treatment of asthma in people age 6 and older. SPIRIVA RESPIMAT is not a treatment for sudden asthma symptoms.


Aging

ProLon FMD is the First Food Technology That Treats Aging

A new study finds that providing the body with a temporary, specifically formulated Fasting Mimicking Diet (FMD™) called ProLon® causes cellular changes, normally generated by several days of consecutive water-only fasting, and may increase health and lifespan by partially turning back the aging clock.


HIV

Research Presents a New Target for HIV Prevention and Treatment

Scientists at the National Institutes of Health have found that the presence of the protein alpha-4 beta-7 integrin on the surface of HIV and its monkey equivalent — simian immunodeficiency virus, or SIV — may help explain why an antibody protected monkeys from SIV in previous experiments.